Hikal Ltd KYS Report: Ownership & Insights | Research 360

10:09 Dec 15

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

251.99

-0.72 (-0.28%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 10:09 Dec 15

251.99

-0.72 (-0.28%)

73/100 High Financial Strength

Quality

44/100 Mid Valuation

Valuation

42/100 Technically Neutral

Technical

SWOT

Strength

4

Weakness

9

Opportunity

1

Threat

0

3.11K

Market Cap (Cr)

307.63

PE Ratio

2.61

Price to Book Ratio

59.77

RSI

4.88 %

Net Profit Margin

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password